If you would like to discuss a nutritional therapy that meets our criteria, please contact us at info@pharmanutria.com.
The link between diet and health is now clear, and it is well known that nutritional therapies can have significant health benefits for a wide range of important health conditions. Our mission is to prove it—at the level of pharmaceutical drugs—by taking promising nutritionals through phase 3 clinical trials and the drug approval process.
Focusing on specific indications, we validate the effectiveness of specific nutritional therapies, create differentiated and effective new products, expand the marketplace, and bring people better health.
Our criteria for selection includes:
We are acquiring a high-potential pipeline of products that meets these criteria, building a portfolio of therapeutic pharmaconutrition products addressing the following indication areas:
Focusing on specific indications, we validate the effectiveness of specific nutritional therapies, create differentiated and effective new products, expand the marketplace, and bring people better health.
Our criteria for selection includes:
- Established safety for human use (via phase 1 clinical trials)
- Proof of effectiveness, at least equivalent to a phase 2 clinical trial
- Intellectual property protection
- Indication representing a large potential market
- Favorable product economics
We are acquiring a high-potential pipeline of products that meets these criteria, building a portfolio of therapeutic pharmaconutrition products addressing the following indication areas:
- Cardiovascular Health
- Weight Management
- Post-Surgical Recovery
- Skin Health
- Muscle Preservation
- Digestive Health
